In a letter to the leaders of the Senate Agricultural Committee, the Biotechnology Innovation Organization (BIO) and dozens of other food and agriculture groups […]
BIO, ag industry groups support Alexis Taylor for USDA Under Secretary Read More »
On June 22, the Senate Commerce Committee approved BIO-supported legislation intended to increase transparency of the business practices of pharmacy benefit managers (PBMs), which
Senate Committee advances PBM transparency legislation Read More »
While some US federal regulators believe the ongoing intensification of mergers and acquisitions in various sectors could jeopardize market competition, M&As can be beneficial
M&As in biotech can help patients, says AskBio Read More »
“Another pandemic is upon us, and policymakers are once again proving slow to respond, to the detriment of global health,” writes Henry B. Skinner,
AMR: ‘We’re already ignoring the next pandemic’ Read More »
On Day 4 – the final episode of Good Day BIO Live – we have interviews with BIO leadership and policy experts on Accelerated
Good Day BIO LIVE! from San Diego – watch Thursday’s episode Read More »
Accelerated Approval, growing misinformation and declining life expectancy, and the need for more resources on the food side of the agency were among the
FDA Commissioner on Accelerated Approval, misinformation, and food Read More »
The Senate Health, Education, Labor and Pensions (HELP) Committee marked up its legislation to reauthorize the Food and Drug Administration (FDA) user fee agreements,
FDA user fee bill marked up by Senate HELP Committee Read More »
The draft of the next Food and Drug Administration (FDA) user fee agreement currently making its way through Congress was developed with close cooperation
PDUFA panelists praise FDA’s cooperation on setting drug approval process Read More »
On Day 3, the Good Day BIO Team brings you exclusive interviews with BIO’s Phyllis Arthur, Novavax’s John Trizzino, and BioGENEius winner Okezue Bell,
Good Day BIO LIVE! from San Diego – watch Wednesday’s episode Read More »
The Food and Drug Administration’s greater reliance on digital tools during the pandemic showed the agency how these tools could be used to expand
FDA officials see benefits of pandemic-driven digitalization Read More »
